Efficacy outcomes and characteristics of patients with multiple myeloma (MM) who achieved sustained minimal residual disease negativity after treatment with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 Meeting Abstract
| Authors: | Munshi, N. C.; Paiva, B.; Martin, T.; Usmani, S.; Lin, Y.; Schecter, J. M.; Jackson, C. C.; Madduri, D.; Zudaire, E.; Yeh, T. M.; Bartlett, J. B.; Pacaud, L.; Akram, M.; Geng, D.; Jagannath, S.; Cohen, A. D.; San-Miguel, J. |
| Abstract Title: | Efficacy outcomes and characteristics of patients with multiple myeloma (MM) who achieved sustained minimal residual disease negativity after treatment with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 4652 |
| End Page: | 4654 |
| Language: | English |
| ACCESSION: | WOS:000893223204295 |
| DOI: | 10.1182/blood-2022-159141 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
